Suzuki Y, Shimozawa N, Yajima S, Inoue K, Orii T, Kondo N
Department of Pediatrics, Gifu University School of Medicine, Japan.
Jpn J Hum Genet. 1996 Mar;41(1):167-75. doi: 10.1007/BF01892624.
Japanese patients with peroxisomal disorders in the pediatric field were screened. Very long chain fatty acid analysis in the serum sphingomyelin was introduced since 1987 and was useful for the first screening of peroxisomal disorders. Seventy-five patients were diagnosed since 1980: 15 patients with Zellweger syndrome, 2 with neonatal adrenoleukodystrophy (ALD), 1 with rhizomelic chondrodysplasia punctata, 1 with Zellweger-like syndrome. 2 with acyl-CoA oxidase deficiency, 2 with bifunctional enzyme deficiency and 52 with X-linked ALD. The incidence of peroxisome-deficient disorders was estimated to be approximately 1 in 800,000 births which is far less than that in the USA. However, the incidence in Okinawa Islands was 1 in 30,000. Japanese Zellweger patients belonged to 5 complementation groups (A, B, C, E, F) and the patients in Okinawa Islands belonged to groups A and C. The results of this screening were useful for genetic counseling, prenatal diagnosis, carrier detection and early medical care of patients with peroxisomal disorders.
对日本儿科领域的过氧化物酶体疾病患者进行了筛查。自1987年起引入了血清鞘磷脂中极长链脂肪酸分析,该分析对过氧化物酶体疾病的初步筛查很有用。自1980年以来共诊断出75例患者:15例患有泽尔韦格综合征,2例患有新生儿肾上腺脑白质营养不良(ALD),1例患有肢根型点状软骨发育不良,1例患有类泽尔韦格综合征,2例患有酰基辅酶A氧化酶缺乏症,2例患有双功能酶缺乏症,52例患有X连锁ALD。过氧化物酶体缺乏症的发病率估计约为每80万例出生中有1例,远低于美国。然而,冲绳岛的发病率为每3万例中有1例。日本泽尔韦格患者属于5个互补组(A、B、C、E、F),冲绳岛的患者属于A组和C组。这项筛查结果对过氧化物酶体疾病患者的遗传咨询、产前诊断、携带者检测和早期医疗护理很有用。